Skip to main content
Top
Published in: BMC Neurology 1/2020

Open Access 01-12-2020 | Multiple Sclerosis | Research article

Vigorous cool room treadmill training to improve walking ability in people with multiple sclerosis who use ambulatory assistive devices: a feasibility study

Authors: Augustine J. Devasahayam, Arthur R. Chaves, Wendy O. Lasisi, Marie E. Curtis, Katie P. Wadden, Liam P. Kelly, Ryan Pretty, Alice Chen, Elizabeth M. Wallack, Caitlin J. Newell, John B. Williams, Hannah Kenny, Matthew B. Downer, Jason McCarthy, Craig S. Moore, Michelle Ploughman

Published in: BMC Neurology | Issue 1/2020

Login to get access

Abstract

Background

Aerobic training has the potential to restore function, stimulate brain repair, and reduce inflammation in people with Multiple Sclerosis (MS). However, disability, fatigue, and heat sensitivity are major barriers to exercise for people with MS. We aimed to determine the feasibility of conducting vigorous harness-supported treadmill training in a room cooled to 16 °C (10 weeks; 3times/week) and examine the longer-term effects on markers of function, brain repair, and inflammation among those using ambulatory aids.

Methods

Ten participants (9 females) aged 29 to 74 years with an Expanded Disability Status Scale ranging from 6 to 7 underwent training (40 to 65% heart rate reserve) starting at 80% self-selected walking speed. Feasibility of conducting vigorous training was assessed using a checklist, which included attendance rates, number of missed appointments, reasons for not attending, adverse events, safety hazards during training, reasons for dropout, tolerance to training load, subjective reporting of symptom worsening during and after exercise, and physiological responses to exercise. Functional outcomes were assessed before, after, and 3 months after training. Walking ability was measured using Timed 25 Foot Walk test and on an instrumented walkway at both fast and self-selected speeds. Fatigue was measured using fatigue/energy/vitality sub-scale of 36-Item Short-Form (SF-36) Health Survey, Fatigue Severity Scale, modified Fatigue Impact Scale. Aerobic fitness (maximal oxygen consumption) was measured using maximal graded exercise test (GXT). Quality-of-life was measured using SF-36 Health Survey. Serum levels of neurotrophin (brain-derived neurotrophic factor) and cytokine (interleukin-6) were assessed before and after GXT.

Results

Eight of the ten participants completed training (attendance rates ≥ 80%). No adverse events were observed. Fast walking speed (cm/s), gait quality (double-support (%)) while walking at self-selected speed, fatigue (modified Fatigue Impact Scale), fitness (maximal workload achieved during GXT), and quality-of-life (physical functioning sub-scale of SF-36) improved significantly after training, and improvements were sustained after 3-months. Improvements in fitness (maximal respiratory exchange ratio and maximal oxygen consumption during GXT) were associated with increased brain-derived neurotrophic factor and decreased interleukin-6.

Conclusion

Vigorous cool room training is feasible and can potentially improve walking, fatigue, fitness, and quality-of-life among people with moderate to severe MS-related disability.

Trial registration

The study was approved by the Newfoundland and Labrador Health Research Ethics Board (reference number: 2018.088) on 11/07/2018 prior to the enrollment of first participant (retrospectively registered at ClinicalTrials.gov: NCT04066972. Registered on 26 August 2019.
Appendix
Available only for authorised users
Literature
1.
go back to reference Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylor BV, et al. Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity. Neurol. 2014;83(11):1022–4.CrossRef Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylor BV, et al. Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity. Neurol. 2014;83(11):1022–4.CrossRef
2.
go back to reference Lassmann H, Van Horssen J, Mahad D. Progressive multiple sclerosis: pathology and pathogenesis. Nat Rev Neurol. 2012;8(11):647.PubMedCrossRef Lassmann H, Van Horssen J, Mahad D. Progressive multiple sclerosis: pathology and pathogenesis. Nat Rev Neurol. 2012;8(11):647.PubMedCrossRef
3.
go back to reference Jensen SK, Michaels NJ, Ilyntskyy S, Keough MB, Kovalchuk O, Yong VW. Multimodal enhancement of remyelination by exercise with a pivotal role for oligodendroglial PGC1alpha. Cell Rep. 2018;24(12):3167–79.PubMedCrossRef Jensen SK, Michaels NJ, Ilyntskyy S, Keough MB, Kovalchuk O, Yong VW. Multimodal enhancement of remyelination by exercise with a pivotal role for oligodendroglial PGC1alpha. Cell Rep. 2018;24(12):3167–79.PubMedCrossRef
4.
go back to reference Rossi S, Furlan R, De Chiara V, Musella A, Lo Giudice T, Mataluni G, et al. Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis. Neurobiol Dis. 2009;36(1):51–9.PubMedCrossRef Rossi S, Furlan R, De Chiara V, Musella A, Lo Giudice T, Mataluni G, et al. Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis. Neurobiol Dis. 2009;36(1):51–9.PubMedCrossRef
5.
go back to reference Gentile A, Musella A, De Vito F, Rizzo FR, Fresegna D, Bullitta S, et al. Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis. Front Immunol. 2019;10(2197). Gentile A, Musella A, De Vito F, Rizzo FR, Fresegna D, Bullitta S, et al. Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis. Front Immunol. 2019;10(2197).
6.
go back to reference Castellano V, White LJ. Serum brain-derived neurotrophic factor response to aerobic exercise in multiple sclerosis. J Neurol Sci. 2008;269(1):85–91.PubMedCrossRef Castellano V, White LJ. Serum brain-derived neurotrophic factor response to aerobic exercise in multiple sclerosis. J Neurol Sci. 2008;269(1):85–91.PubMedCrossRef
7.
go back to reference Bansi J, Bloch W, Gamper U, Kesselring J. Training in MS: influence of two different endurance training protocols (aquatic versus overland) on cytokine and neurotrophin concentrations during three week randomized controlled trial. Mult Scler. 2012;19(5):613–21.PubMedCrossRef Bansi J, Bloch W, Gamper U, Kesselring J. Training in MS: influence of two different endurance training protocols (aquatic versus overland) on cytokine and neurotrophin concentrations during three week randomized controlled trial. Mult Scler. 2012;19(5):613–21.PubMedCrossRef
8.
go back to reference Negaresh R, Motl RW, Zimmer P, Mokhtarzade M, Baker JS. Effects of exercise training on multiple sclerosis biomarkers of central nervous system and disease status: a systematic review of intervention studies. Eur J Neurol. 2019;26(5):711–21.PubMedCrossRef Negaresh R, Motl RW, Zimmer P, Mokhtarzade M, Baker JS. Effects of exercise training on multiple sclerosis biomarkers of central nervous system and disease status: a systematic review of intervention studies. Eur J Neurol. 2019;26(5):711–21.PubMedCrossRef
9.
go back to reference Ploughman M, Eskes GA, Kelly LP, Kirkland MC, Devasahayam AJ, Wallack EM, et al. Synergistic benefits of combined aerobic and cognitive training on fluid intelligence and the role of IGF-1 in chronic stroke. Neurorehabil Neural Repair. 2019;33(3):199–212.PubMedCrossRef Ploughman M, Eskes GA, Kelly LP, Kirkland MC, Devasahayam AJ, Wallack EM, et al. Synergistic benefits of combined aerobic and cognitive training on fluid intelligence and the role of IGF-1 in chronic stroke. Neurorehabil Neural Repair. 2019;33(3):199–212.PubMedCrossRef
10.
go back to reference Briken S, Rosenkranz SC, Keminer O, Patra S, Ketels G, Heesen C, et al. Effects of exercise on Irisin, BDNF and IL-6 serum levels in patients with progressive multiple sclerosis. J Neuroimmunol. 2016;299:53–8.PubMedCrossRef Briken S, Rosenkranz SC, Keminer O, Patra S, Ketels G, Heesen C, et al. Effects of exercise on Irisin, BDNF and IL-6 serum levels in patients with progressive multiple sclerosis. J Neuroimmunol. 2016;299:53–8.PubMedCrossRef
12.
go back to reference Devasahayam AJ, Downer MB, Ploughman M. The effects of aerobic exercise on the recovery of walking ability and neuroplasticity in people with multiple sclerosis: a systematic review of animal and clinical studies. Mult Scler Int. 2017;2017:12. Devasahayam AJ, Downer MB, Ploughman M. The effects of aerobic exercise on the recovery of walking ability and neuroplasticity in people with multiple sclerosis: a systematic review of animal and clinical studies. Mult Scler Int. 2017;2017:12.
13.
go back to reference Schulz KH, Gold SM, Witte J, Bartsch K, Lang UE, Hellweg R, et al. Impact of aerobic training on immune-endocrine parameters, neurotrophic factors, quality of life and coordinative function in multiple sclerosis. J Neurol Sci. 2004;225(1–2):11–8.PubMedCrossRef Schulz KH, Gold SM, Witte J, Bartsch K, Lang UE, Hellweg R, et al. Impact of aerobic training on immune-endocrine parameters, neurotrophic factors, quality of life and coordinative function in multiple sclerosis. J Neurol Sci. 2004;225(1–2):11–8.PubMedCrossRef
14.
go back to reference Ploughman M. A new era of multiple sclerosis rehabilitation: lessons from stroke. Lancet Neurol. 2017;16(10):768–9.PubMedCrossRef Ploughman M. A new era of multiple sclerosis rehabilitation: lessons from stroke. Lancet Neurol. 2017;16(10):768–9.PubMedCrossRef
15.
go back to reference Sawka MN, Coyle EF. Influence of body water and blood volume on thermoregulation and exercise performance in the heat. Exerc Sport Sci Rev. 1999;27:167–218.PubMed Sawka MN, Coyle EF. Influence of body water and blood volume on thermoregulation and exercise performance in the heat. Exerc Sport Sci Rev. 1999;27:167–218.PubMed
16.
go back to reference Johnson JM, Proppe DW. Cardiovascular adjustments to heat stress. In: Y.S P, editor. Compr Physiol, Environ Physiol. 1: Am Physiol Soc; 1996. p. 215–243. Johnson JM, Proppe DW. Cardiovascular adjustments to heat stress. In: Y.S P, editor. Compr Physiol, Environ Physiol. 1: Am Physiol Soc; 1996. p. 215–243.
17.
go back to reference Sawka MN, Wenger CB, Pandolf KB. Thermoregulatory responses to acute exercise-heat stress and heat acclimation. In: Y.S P, editor. Compr Physiol, Environ Physiol. 4: Ame Physiol Soc; 1996. p. 157–186. Sawka MN, Wenger CB, Pandolf KB. Thermoregulatory responses to acute exercise-heat stress and heat acclimation. In: Y.S P, editor. Compr Physiol, Environ Physiol. 4: Ame Physiol Soc; 1996. p. 157–186.
18.
go back to reference Guthrie TC, Nelson DA. Influence of temperature changes on multiple sclerosis: critical review of mechanisms and research potential. J Neurol Sci. 1995;129(1):1–8.PubMedCrossRef Guthrie TC, Nelson DA. Influence of temperature changes on multiple sclerosis: critical review of mechanisms and research potential. J Neurol Sci. 1995;129(1):1–8.PubMedCrossRef
19.
go back to reference Romberg A, Ikonen A, Ruutiainen J, Virtanen A, Hamalainen P. The effects of heat stress on physical functioning in persons with multiple sclerosis. J Neurol Sci. 2012;319(1–2):42–6.PubMedCrossRef Romberg A, Ikonen A, Ruutiainen J, Virtanen A, Hamalainen P. The effects of heat stress on physical functioning in persons with multiple sclerosis. J Neurol Sci. 2012;319(1–2):42–6.PubMedCrossRef
20.
go back to reference Backus D. Increasing physical activity and participation in people with multiple sclerosis: A review. Arch Phys Med Rehabil. 2016;97(9, Supplement):S210–S7.PubMedCrossRef Backus D. Increasing physical activity and participation in people with multiple sclerosis: A review. Arch Phys Med Rehabil. 2016;97(9, Supplement):S210–S7.PubMedCrossRef
21.
go back to reference Skjerbaek AG, Moller AB, Jensen E, Vissing K, Sorensen H, Nybo L, et al. Heat sensitive persons with multiple sclerosis are more tolerant to resistance exercise than to endurance exercise. Mult Scler. 2013;19(7):932–40.PubMedCrossRef Skjerbaek AG, Moller AB, Jensen E, Vissing K, Sorensen H, Nybo L, et al. Heat sensitive persons with multiple sclerosis are more tolerant to resistance exercise than to endurance exercise. Mult Scler. 2013;19(7):932–40.PubMedCrossRef
22.
go back to reference Grover G, Ploughman M, Philpott DT, Kelly LP, Devasahayam AJ, Wadden K, et al. Environmental temperature and exercise modality independently impact central and muscle fatigue among people with multiple sclerosis. Mult Scler J Exp Transl Clin. 2017;3(4):2055217317747625.PubMedPubMedCentral Grover G, Ploughman M, Philpott DT, Kelly LP, Devasahayam AJ, Wadden K, et al. Environmental temperature and exercise modality independently impact central and muscle fatigue among people with multiple sclerosis. Mult Scler J Exp Transl Clin. 2017;3(4):2055217317747625.PubMedPubMedCentral
23.
go back to reference Devasahayam A, Kelly L, Wallack E, Chaves A, Curtis M, Newell C, et al. The effects of maximal aerobic exercise on serum Neurotrophins and inflammatory cytokines in progressive multiple sclerosis. Stockholm, Sweden: 35th congress of the European Committee for Treatment and Research in Multiple Sclerosis; 2019. Devasahayam A, Kelly L, Wallack E, Chaves A, Curtis M, Newell C, et al. The effects of maximal aerobic exercise on serum Neurotrophins and inflammatory cytokines in progressive multiple sclerosis. Stockholm, Sweden: 35th congress of the European Committee for Treatment and Research in Multiple Sclerosis; 2019.
24.
go back to reference Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. Pilot Feasibility Stud. 2016;2(1):64.PubMedPubMedCentralCrossRef Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. Pilot Feasibility Stud. 2016;2(1):64.PubMedPubMedCentralCrossRef
25.
go back to reference Hertzog MA. Considerations in determining sample size for pilot studies. Res Nurs Health. 2008;31(2):180–91.PubMedCrossRef Hertzog MA. Considerations in determining sample size for pilot studies. Res Nurs Health. 2008;31(2):180–91.PubMedCrossRef
26.
go back to reference Lo AC, Triche EW. Improving gait in multiple sclerosis using robot-assisted, body weight supported treadmill training. Neurorehabil Neural Repair. 2008;22(6):661–71.PubMedCrossRef Lo AC, Triche EW. Improving gait in multiple sclerosis using robot-assisted, body weight supported treadmill training. Neurorehabil Neural Repair. 2008;22(6):661–71.PubMedCrossRef
27.
go back to reference Swinnen E, Beckwée D, Pinte D, Meeusen R, Baeyens J-P, Kerckhofs E. Treadmill training in multiple sclerosis: can body weight support or robot assistance provide added value? Syst Rev Mult Scler Int. 2012;2012:240274. Swinnen E, Beckwée D, Pinte D, Meeusen R, Baeyens J-P, Kerckhofs E. Treadmill training in multiple sclerosis: can body weight support or robot assistance provide added value? Syst Rev Mult Scler Int. 2012;2012:240274.
28.
go back to reference Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302.PubMedPubMedCentralCrossRef Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302.PubMedPubMedCentralCrossRef
29.
go back to reference Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurol. 1983;33(11):1444.CrossRef Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurol. 1983;33(11):1444.CrossRef
30.
go back to reference Shephard RJ. PAR-Q, Canadian Home Fitness Test and exercise screening alternatives. Sport Med (Auckland, NZ). 1988;5(3):185–95.CrossRef Shephard RJ. PAR-Q, Canadian Home Fitness Test and exercise screening alternatives. Sport Med (Auckland, NZ). 1988;5(3):185–95.CrossRef
31.
go back to reference Thomas S, Reading J, Shephard RJ. Revision of the physical activity readiness questionnaire (PAR-Q). Canadian journal of sport sciences =. J Can Des Sci Du Sport. 1992;17(4):338–45. Thomas S, Reading J, Shephard RJ. Revision of the physical activity readiness questionnaire (PAR-Q). Canadian journal of sport sciences =. J Can Des Sci Du Sport. 1992;17(4):338–45.
32.
go back to reference Warburton DE, Gledhill N, Jamnik VK, Bredin SS, McKenzie DC, Stone J, et al. Evidence-based risk assessment and recommendations for physical activity clearance: consensus document 2011. Appl Physiol Nutr Metab. 2011;36(S1):S266–S98.PubMedCrossRef Warburton DE, Gledhill N, Jamnik VK, Bredin SS, McKenzie DC, Stone J, et al. Evidence-based risk assessment and recommendations for physical activity clearance: consensus document 2011. Appl Physiol Nutr Metab. 2011;36(S1):S266–S98.PubMedCrossRef
33.
go back to reference Giovannoni G, Cutter G, Sormani MP, Belachew S, Hyde R, Koendgen H, et al. Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses. Mult Scler Relat Disord. 2017;12:70–8.PubMedCrossRef Giovannoni G, Cutter G, Sormani MP, Belachew S, Hyde R, Koendgen H, et al. Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses. Mult Scler Relat Disord. 2017;12:70–8.PubMedCrossRef
34.
go back to reference Fischer JS, Rudick RA, Cutter GR, Reingold SC. The multiple sclerosis functional composite measure (MSFC): an integrated approach to MS clinical outcome assessment. Mult Scler. 1999;5(4):244–50.PubMedCrossRef Fischer JS, Rudick RA, Cutter GR, Reingold SC. The multiple sclerosis functional composite measure (MSFC): an integrated approach to MS clinical outcome assessment. Mult Scler. 1999;5(4):244–50.PubMedCrossRef
35.
go back to reference Miller AE, Thompson A, Weinshenker BG, Confavreux C, Cookfair DL, Willoughby E, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain. 1999;122(5):871–82.PubMedCrossRef Miller AE, Thompson A, Weinshenker BG, Confavreux C, Cookfair DL, Willoughby E, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain. 1999;122(5):871–82.PubMedCrossRef
36.
go back to reference Motl RW, Cohen JA, Benedict R, Phillips G, LaRocca N, Hudson LD, et al. Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis. Mult Scler. 2017;23(5):704–10.PubMedPubMedCentralCrossRef Motl RW, Cohen JA, Benedict R, Phillips G, LaRocca N, Hudson LD, et al. Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis. Mult Scler. 2017;23(5):704–10.PubMedPubMedCentralCrossRef
37.
go back to reference Vallabhajosula S, Humphrey SK, Cook AJ, Freund JE. Concurrent validity of the Zeno walkway for measuring spatiotemporal gait parameters in older adults. J Geriatr Phys Ther. 2001;2017. Vallabhajosula S, Humphrey SK, Cook AJ, Freund JE. Concurrent validity of the Zeno walkway for measuring spatiotemporal gait parameters in older adults. J Geriatr Phys Ther. 2001;2017.
38.
go back to reference Kirkland MC, Wallack EM, Rancourt SN, Ploughman M. Comparing three dual-task methods and the relationship to physical and cognitive impairment in people with multiple sclerosis and controls. Mult Scler Int. 2015;2015:7. Kirkland MC, Wallack EM, Rancourt SN, Ploughman M. Comparing three dual-task methods and the relationship to physical and cognitive impairment in people with multiple sclerosis and controls. Mult Scler Int. 2015;2015:7.
39.
go back to reference Ware JE. Scoring the SF-36. SF-36 Health Surv: Man Interpretation Guide. 1993. Ware JE. Scoring the SF-36. SF-36 Health Surv: Man Interpretation Guide. 1993.
41.
go back to reference Deng N, Guyer R, Ware JE Jr. Energy, fatigue, or both? A bifactor modeling approach to the conceptualization and measurement of vitality. Qual Life Res : Int J Qual Life Aspects Treat, Care Rehabil. 2015;24(1):81–93.CrossRef Deng N, Guyer R, Ware JE Jr. Energy, fatigue, or both? A bifactor modeling approach to the conceptualization and measurement of vitality. Qual Life Res : Int J Qual Life Aspects Treat, Care Rehabil. 2015;24(1):81–93.CrossRef
42.
go back to reference Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121–3.PubMedCrossRef Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121–3.PubMedCrossRef
43.
go back to reference Learmonth YC, Dlugonski D, Pilutti LA, Sandroff BM, Klaren R, Motl RW. Psychometric properties of the fatigue severity scale and the modified fatigue impact scale. J Neurol Sci. 2013;331(1–2):102–7.PubMedCrossRef Learmonth YC, Dlugonski D, Pilutti LA, Sandroff BM, Klaren R, Motl RW. Psychometric properties of the fatigue severity scale and the modified fatigue impact scale. J Neurol Sci. 2013;331(1–2):102–7.PubMedCrossRef
44.
go back to reference Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1994;18(Suppl 1):S79–83.CrossRef Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1994;18(Suppl 1):S79–83.CrossRef
45.
go back to reference Tellez N, Rio J, Tintore M, Nos C, Galan I, Montalban X. Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS? Mult Scler (Houndmills, Basingstoke, England). 2005;11(2):198–202. Tellez N, Rio J, Tintore M, Nos C, Galan I, Montalban X. Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS? Mult Scler (Houndmills, Basingstoke, England). 2005;11(2):198–202.
46.
go back to reference Kelly LP, Devasahayam AJ, Chaves AR, Wallack EM, McCarthy J, Basset FA, et al. Intensifying functional task practice to meet aerobic training guidelines in stroke survivors. Front Physiol. 2017;8:809.PubMedPubMedCentralCrossRef Kelly LP, Devasahayam AJ, Chaves AR, Wallack EM, McCarthy J, Basset FA, et al. Intensifying functional task practice to meet aerobic training guidelines in stroke survivors. Front Physiol. 2017;8:809.PubMedPubMedCentralCrossRef
47.
go back to reference American College of Sports Medicine. Health-related physical fitness testing and interpretation. In: L.S P, editor. ACSM's Guidelines for Exercise Testing and Prescription. Baltimore, MD: Lippincott Williams & Wilkins; 2013. p. 60–107. American College of Sports Medicine. Health-related physical fitness testing and interpretation. In: L.S P, editor. ACSM's Guidelines for Exercise Testing and Prescription. Baltimore, MD: Lippincott Williams & Wilkins; 2013. p. 60–107.
48.
go back to reference Price RD, Milne SA, Sharkey J, Matsuoka N. Advances in small molecules promoting neurotrophic function. Pharmacol Ther. 2007;115(2):292–306.PubMedCrossRef Price RD, Milne SA, Sharkey J, Matsuoka N. Advances in small molecules promoting neurotrophic function. Pharmacol Ther. 2007;115(2):292–306.PubMedCrossRef
49.
go back to reference Ignaszewski M, Lau B, Wong S, Isserow S. The science of exercise prescription: Martti Karvonen and his contributions. Br Columbia Med J. 2017;59(1). Ignaszewski M, Lau B, Wong S, Isserow S. The science of exercise prescription: Martti Karvonen and his contributions. Br Columbia Med J. 2017;59(1).
50.
go back to reference Karvonen MJ. The effects of training on heart rate: a longitudinal study. Ann Med Exp Biol Fenn. 1957;35:307–15.PubMed Karvonen MJ. The effects of training on heart rate: a longitudinal study. Ann Med Exp Biol Fenn. 1957;35:307–15.PubMed
51.
go back to reference Severo-Silveira L, Dornelles MP, Lima ESFX, Marchiori CL, Medeiros TM, Pappas E, et al. Progressive workload periodization maximizes effects of nordic hamstring exercise on muscle injury risk factors. J Strength Cond Res. 2018. Severo-Silveira L, Dornelles MP, Lima ESFX, Marchiori CL, Medeiros TM, Pappas E, et al. Progressive workload periodization maximizes effects of nordic hamstring exercise on muscle injury risk factors. J Strength Cond Res. 2018.
52.
go back to reference Curtin F, Schulz P. Multiple correlations and Bonferroni's correction. Biol Psychiatry. 1998;44(8):775–7.PubMedCrossRef Curtin F, Schulz P. Multiple correlations and Bonferroni's correction. Biol Psychiatry. 1998;44(8):775–7.PubMedCrossRef
53.
go back to reference Meinert C, Tonascia S. Clinical trials: design, conduct and analysis. Monographs in epidemiology and biostatistics. New York: Oxford University Press; 1986.CrossRef Meinert C, Tonascia S. Clinical trials: design, conduct and analysis. Monographs in epidemiology and biostatistics. New York: Oxford University Press; 1986.CrossRef
54.
go back to reference Schumacher GA, Beebe G, Kibler RF, Kurland LT, Kurtzke JF, McDowell F, et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci. 1965;122:552–68.PubMedCrossRef Schumacher GA, Beebe G, Kibler RF, Kurland LT, Kurtzke JF, McDowell F, et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci. 1965;122:552–68.PubMedCrossRef
55.
go back to reference Avasarala J. Redefining acute relapses in multiple sclerosis: implications for phase 3 clinical trials and treatment algorithms. Innov Clin Neurosci. 2017;14(3–4):38–40.PubMedPubMedCentral Avasarala J. Redefining acute relapses in multiple sclerosis: implications for phase 3 clinical trials and treatment algorithms. Innov Clin Neurosci. 2017;14(3–4):38–40.PubMedPubMedCentral
56.
go back to reference Goldman MD, Motl RW, Scagnelli J, Pula JH, Sosnoff JJ, Cadavid D. Clinically meaningful performance benchmarks in MS: timed 25-foot walk and the real world. Neurol. 2013;81(21):1856–63.CrossRef Goldman MD, Motl RW, Scagnelli J, Pula JH, Sosnoff JJ, Cadavid D. Clinically meaningful performance benchmarks in MS: timed 25-foot walk and the real world. Neurol. 2013;81(21):1856–63.CrossRef
57.
go back to reference Hobart J, Blight AR, Goodman A, Lynn F, Putzki N. Timed 25-foot walk: direct evidence that improving 20% or greater is clinically meaningful in MS. Neurology. 2013;80(16):1509–17.PubMedCrossRef Hobart J, Blight AR, Goodman A, Lynn F, Putzki N. Timed 25-foot walk: direct evidence that improving 20% or greater is clinically meaningful in MS. Neurology. 2013;80(16):1509–17.PubMedCrossRef
58.
go back to reference Sola-Valls N, Blanco Y, Sepúlveda M, Llufriu S, Martínez-Lapiscina EH, Zubizarreta I, et al. Combined walking outcome measures identify clinically meaningful response to prolonged-release fampridine. Ther Adv Neurol Disord. 2018;11:1756286418780007.PubMedPubMedCentralCrossRef Sola-Valls N, Blanco Y, Sepúlveda M, Llufriu S, Martínez-Lapiscina EH, Zubizarreta I, et al. Combined walking outcome measures identify clinically meaningful response to prolonged-release fampridine. Ther Adv Neurol Disord. 2018;11:1756286418780007.PubMedPubMedCentralCrossRef
59.
go back to reference Pearson M, Dieberg G, Smart N. Exercise as a therapy for improvement of walking ability in adults with multiple sclerosis: A meta-analysis. Arch Phys Med Rehabil. 2015;96(7):1339–48.e7.PubMedCrossRef Pearson M, Dieberg G, Smart N. Exercise as a therapy for improvement of walking ability in adults with multiple sclerosis: A meta-analysis. Arch Phys Med Rehabil. 2015;96(7):1339–48.e7.PubMedCrossRef
60.
go back to reference Learmonth YC, Dlugonski DD, Pilutti LA, Sandroff BM, Motl RW. The reliability, precision and clinically meaningful change of walking assessments in multiple sclerosis. Mult Scler. 2013;19(13):1784–91.PubMedCrossRef Learmonth YC, Dlugonski DD, Pilutti LA, Sandroff BM, Motl RW. The reliability, precision and clinically meaningful change of walking assessments in multiple sclerosis. Mult Scler. 2013;19(13):1784–91.PubMedCrossRef
61.
go back to reference Nordin Å, Taft C, Lundgren-Nilsson Å, Dencker A. Minimal important differences for fatigue patient reported outcome measures-A systematic review. BMC Med Res Methodol. 2016;16(62). Nordin Å, Taft C, Lundgren-Nilsson Å, Dencker A. Minimal important differences for fatigue patient reported outcome measures-A systematic review. BMC Med Res Methodol. 2016;16(62).
62.
go back to reference Heine M, Verschuren O, Kwakkel G. Validity of oxygen uptake efficiency slope in patients with multiple sclerosis. J Rehabil Med. 2014;46(7):656.PubMedCrossRef Heine M, Verschuren O, Kwakkel G. Validity of oxygen uptake efficiency slope in patients with multiple sclerosis. J Rehabil Med. 2014;46(7):656.PubMedCrossRef
63.
go back to reference Uchida K. Unit of oxygen uptake efficiency slope. The Journal of Physical Fitness and Sports Medicine. 2018;7(3):171–5.CrossRef Uchida K. Unit of oxygen uptake efficiency slope. The Journal of Physical Fitness and Sports Medicine. 2018;7(3):171–5.CrossRef
64.
go back to reference Hays RD, Morales LS. The RAND-36 measure of health-related quality of life. Ann Med. 2001;33(5):350–7.PubMedCrossRef Hays RD, Morales LS. The RAND-36 measure of health-related quality of life. Ann Med. 2001;33(5):350–7.PubMedCrossRef
65.
go back to reference Samsa G, Edelman D, Rothman M, Williams G, Lipscomb J, Matchar D. Determining clinically important differences in health status measures: a general approach with illustration to the health utilities index mark II. PharmacoEconomics. 1999;15(2):141.PubMedCrossRef Samsa G, Edelman D, Rothman M, Williams G, Lipscomb J, Matchar D. Determining clinically important differences in health status measures: a general approach with illustration to the health utilities index mark II. PharmacoEconomics. 1999;15(2):141.PubMedCrossRef
66.
go back to reference Uhthoff W. Untersuchungen über die bei der multiplen Herdsklerose vorkonimenden Augenstörungen. Archiv für Psychiatrie und Nervenkrankheiten - Eur Arch Psychiatry Clin Neurosci. 1890;21(2):305–410. Uhthoff W. Untersuchungen über die bei der multiplen Herdsklerose vorkonimenden Augenstörungen. Archiv für Psychiatrie und Nervenkrankheiten - Eur Arch Psychiatry Clin Neurosci. 1890;21(2):305–410.
67.
go back to reference Watson CW. Effect of lowering of body temperature on the symptoms and signs of multiple sclerosis. N Engl J Med. 1959;261(25):1253–9.PubMedCrossRef Watson CW. Effect of lowering of body temperature on the symptoms and signs of multiple sclerosis. N Engl J Med. 1959;261(25):1253–9.PubMedCrossRef
68.
go back to reference Boynton B, Garramone P, Buca J. Observations on the effects of cool baths for patients with multiple sclerosis. Phys Ther Rev. 1959;39(5):297–9.PubMedCrossRef Boynton B, Garramone P, Buca J. Observations on the effects of cool baths for patients with multiple sclerosis. Phys Ther Rev. 1959;39(5):297–9.PubMedCrossRef
69.
go back to reference Bassett S, Lake B. Use of cold applications in the management of spasticity; report of three cases. Phys Ther Rev. 1958;38(5):333.PubMedCrossRef Bassett S, Lake B. Use of cold applications in the management of spasticity; report of three cases. Phys Ther Rev. 1958;38(5):333.PubMedCrossRef
70.
go back to reference Grahn DA, vLS MJ, Heller HC. Cooling via one hand improves physical performance in heat-sensitive individuals with multiple sclerosis: A preliminary study. BMC Neurol. 2008;8(1):14.PubMedPubMedCentralCrossRef Grahn DA, vLS MJ, Heller HC. Cooling via one hand improves physical performance in heat-sensitive individuals with multiple sclerosis: A preliminary study. BMC Neurol. 2008;8(1):14.PubMedPubMedCentralCrossRef
71.
go back to reference Scherokman BJ, Selhorst JB, Waybright EA, Jabbari B, Bryan GE, Maitland CG. Improved optic nerve conduction with ingestion of ice water. Ann Neurol. 1985;17(4):418–9.PubMedCrossRef Scherokman BJ, Selhorst JB, Waybright EA, Jabbari B, Bryan GE, Maitland CG. Improved optic nerve conduction with ingestion of ice water. Ann Neurol. 1985;17(4):418–9.PubMedCrossRef
72.
go back to reference Miller E, Kostka J, Włodarczyk T, Dugué B. Whole-body cryostimulation (cryotherapy) provides benefits for fatigue and functional status in multiple sclerosis patients. A case–control study. Acta Neurol Scand. 2016;134(6):420–6.PubMedCrossRef Miller E, Kostka J, Włodarczyk T, Dugué B. Whole-body cryostimulation (cryotherapy) provides benefits for fatigue and functional status in multiple sclerosis patients. A case–control study. Acta Neurol Scand. 2016;134(6):420–6.PubMedCrossRef
73.
go back to reference Ückert S. Cryo and cold application. Cold application in training & competition: The influence of temperature on your athletic performance. Germany: Meyer & Meyer Sport. 2014:73–102. Ückert S. Cryo and cold application. Cold application in training & competition: The influence of temperature on your athletic performance. Germany: Meyer & Meyer Sport. 2014:73–102.
74.
go back to reference Wewege MA, Ahn D, Yu J, Liou K, Keech A. High-Intensity Interval Training for Patients With Cardiovascular Disease-Is It Safe? A Systematic Review. J Am Heart Assoc. 2018;7(21):e009305-e.CrossRef Wewege MA, Ahn D, Yu J, Liou K, Keech A. High-Intensity Interval Training for Patients With Cardiovascular Disease-Is It Safe? A Systematic Review. J Am Heart Assoc. 2018;7(21):e009305-e.CrossRef
75.
go back to reference Boyne P, Dunning K, Carl D, Gerson M, Khoury J, Rockwell B, et al. High-intensity interval training and moderate-intensity continuous training in ambulatory chronic stroke: feasibility study. Phys Ther. 2016;96(10):1533–44.PubMedPubMedCentralCrossRef Boyne P, Dunning K, Carl D, Gerson M, Khoury J, Rockwell B, et al. High-intensity interval training and moderate-intensity continuous training in ambulatory chronic stroke: feasibility study. Phys Ther. 2016;96(10):1533–44.PubMedPubMedCentralCrossRef
76.
go back to reference Witlox L, Velthuis MJ, Boer JH, Bisschop CNS, van der Wall E, van der Meulen WJ, et al. Attendance and compliance with an exercise program during localized breast cancer treatment in a randomized controlled trial: the PACT study. PLoS One. 2019;14(5):e0215517.PubMedPubMedCentralCrossRef Witlox L, Velthuis MJ, Boer JH, Bisschop CNS, van der Wall E, van der Meulen WJ, et al. Attendance and compliance with an exercise program during localized breast cancer treatment in a randomized controlled trial: the PACT study. PLoS One. 2019;14(5):e0215517.PubMedPubMedCentralCrossRef
77.
go back to reference Franklin BA, Billecke S. Putting the benefits and risks of aerobic exercise in perspective. Curr Sports Med Rep. 2012;11(4):201–8.PubMedCrossRef Franklin BA, Billecke S. Putting the benefits and risks of aerobic exercise in perspective. Curr Sports Med Rep. 2012;11(4):201–8.PubMedCrossRef
78.
go back to reference Straudi S, Fanciullacci C, Martinuzzi C, Pavarelli C, Rossi B, Chisari C, et al. The effects of robot-assisted gait training in progressive multiple sclerosis: A randomized controlled trial. Mult Scler (Houndmills, Basingstoke, England). 2015;22(3):373–84.PubMedCrossRef Straudi S, Fanciullacci C, Martinuzzi C, Pavarelli C, Rossi B, Chisari C, et al. The effects of robot-assisted gait training in progressive multiple sclerosis: A randomized controlled trial. Mult Scler (Houndmills, Basingstoke, England). 2015;22(3):373–84.PubMedCrossRef
79.
go back to reference Filingeri D, Chaseling G, Hoang P, Barnett M, Davis SL, Jay O. Afferent thermosensory function in relapsing–remitting multiple sclerosis following exercise-induced increases in body temperature. Exp Physiol. 2017;102(8):887–93.PubMedCrossRef Filingeri D, Chaseling G, Hoang P, Barnett M, Davis SL, Jay O. Afferent thermosensory function in relapsing–remitting multiple sclerosis following exercise-induced increases in body temperature. Exp Physiol. 2017;102(8):887–93.PubMedCrossRef
80.
go back to reference Ploughman M. Breaking down the barriers to physical activity among people with multiple sclerosis – a narrative review. Phys Ther Rev. 2017;22(3–4):124–32.CrossRef Ploughman M. Breaking down the barriers to physical activity among people with multiple sclerosis – a narrative review. Phys Ther Rev. 2017;22(3–4):124–32.CrossRef
81.
go back to reference Ploughman M, Harris C, Wallack EM, Drodge O, Beaulieu S, Mayo N, et al. Predictors of exercise participation in ambulatory and non-ambulatory older people with multiple sclerosis. PeerJ. 2015;3:e1158.PubMedPubMedCentralCrossRef Ploughman M, Harris C, Wallack EM, Drodge O, Beaulieu S, Mayo N, et al. Predictors of exercise participation in ambulatory and non-ambulatory older people with multiple sclerosis. PeerJ. 2015;3:e1158.PubMedPubMedCentralCrossRef
82.
go back to reference Pilutti LA, Lelli DA, Paulseth JE, Crome M, Jiang S, Rathbone MP, et al. Effects of 12 weeks of supported treadmill training on functional ability and quality of life in progressive multiple sclerosis: a pilot study. Arch Phys Med Rehabil. 2011;92(1):31–6.PubMedCrossRef Pilutti LA, Lelli DA, Paulseth JE, Crome M, Jiang S, Rathbone MP, et al. Effects of 12 weeks of supported treadmill training on functional ability and quality of life in progressive multiple sclerosis: a pilot study. Arch Phys Med Rehabil. 2011;92(1):31–6.PubMedCrossRef
83.
go back to reference Coleman CI, Sobieraj DM, Marinucci LN. Minimally important clinical difference of the timed 25-foot walk test: results from a randomized controlled trial in patients with multiple sclerosis. Curr Med Res Opin. 2012;28(1):49–56.PubMedCrossRef Coleman CI, Sobieraj DM, Marinucci LN. Minimally important clinical difference of the timed 25-foot walk test: results from a randomized controlled trial in patients with multiple sclerosis. Curr Med Res Opin. 2012;28(1):49–56.PubMedCrossRef
84.
go back to reference Schwartz I, Sajin A, Moreh E, Fisher I, Neeb M, Forest A, et al. Robot-assisted gait training in multiple sclerosis patients: a randomized trial. Mult Scler. 2012;18(6):881–90.PubMedCrossRef Schwartz I, Sajin A, Moreh E, Fisher I, Neeb M, Forest A, et al. Robot-assisted gait training in multiple sclerosis patients: a randomized trial. Mult Scler. 2012;18(6):881–90.PubMedCrossRef
85.
go back to reference Straudi S, Benedetti MG, Venturini E, Manca M, Foti C, Basaglia N. Does robot-assisted gait training ameliorate gait abnormalities in multiple sclerosis? A pilot randomized-control trial. NeuroRehabilitation. 2013;33(4):555–63.PubMedCrossRef Straudi S, Benedetti MG, Venturini E, Manca M, Foti C, Basaglia N. Does robot-assisted gait training ameliorate gait abnormalities in multiple sclerosis? A pilot randomized-control trial. NeuroRehabilitation. 2013;33(4):555–63.PubMedCrossRef
86.
go back to reference Gutierrez GM, Chow JW, Tillman MD, McCoy SC, Castellano V, White LJ. Resistance training improves gait kinematics in persons with multiple sclerosis. Arch Phys Med Rehabil. 2005;86(9):1824–9.PubMedCrossRef Gutierrez GM, Chow JW, Tillman MD, McCoy SC, Castellano V, White LJ. Resistance training improves gait kinematics in persons with multiple sclerosis. Arch Phys Med Rehabil. 2005;86(9):1824–9.PubMedCrossRef
87.
go back to reference Willingham TB, Melbourn J, Moldavskiy M, McCully KK, Backus D. Case report: effect of antigravity treadmill training on muscle oxidative capacity, muscle endurance, and walking function in a person with multiple sclerosis. Int J MS Care. 2018;20(4):186–90.PubMedPubMedCentralCrossRef Willingham TB, Melbourn J, Moldavskiy M, McCully KK, Backus D. Case report: effect of antigravity treadmill training on muscle oxidative capacity, muscle endurance, and walking function in a person with multiple sclerosis. Int J MS Care. 2018;20(4):186–90.PubMedPubMedCentralCrossRef
88.
go back to reference Giesser B, Beres-Jones J, Budovitch A, Herlihy E, Harkema S. Locomotor training using body weight support on a treadmill improves mobility in persons with multiple sclerosis: a pilot study. Mult Scler. 2007;13(2):224–31.PubMedCrossRef Giesser B, Beres-Jones J, Budovitch A, Herlihy E, Harkema S. Locomotor training using body weight support on a treadmill improves mobility in persons with multiple sclerosis: a pilot study. Mult Scler. 2007;13(2):224–31.PubMedCrossRef
89.
go back to reference Beer S, Aschbacher B, Manoglou D, Gamper E, Kool J, Kesselring J. Robot-assisted gait training in multiple sclerosis: a pilot randomized trial. Mult Scler. 2007;14(2):231–6.PubMedCrossRef Beer S, Aschbacher B, Manoglou D, Gamper E, Kool J, Kesselring J. Robot-assisted gait training in multiple sclerosis: a pilot randomized trial. Mult Scler. 2007;14(2):231–6.PubMedCrossRef
90.
go back to reference Pompa A, Morone G, Iosa M, Pace L, Catani S, Casillo P, et al. Does robot-assisted gait training improve ambulation in highly disabled multiple sclerosis people? A pilot randomized control trial. Mult Scler. 2017;23(5):696–703.PubMedCrossRef Pompa A, Morone G, Iosa M, Pace L, Catani S, Casillo P, et al. Does robot-assisted gait training improve ambulation in highly disabled multiple sclerosis people? A pilot randomized control trial. Mult Scler. 2017;23(5):696–703.PubMedCrossRef
91.
go back to reference Vaney C, Gattlen B, Lugon-Moulin V, Meichtry A, Hausammann R, Foinant D, et al. Robotic-assisted step training (lokomat) not superior to equal intensity of over-ground rehabilitation in patients with multiple sclerosis. Neurorehabil Neural Repair. 2012;26(3):212–21.PubMedCrossRef Vaney C, Gattlen B, Lugon-Moulin V, Meichtry A, Hausammann R, Foinant D, et al. Robotic-assisted step training (lokomat) not superior to equal intensity of over-ground rehabilitation in patients with multiple sclerosis. Neurorehabil Neural Repair. 2012;26(3):212–21.PubMedCrossRef
92.
go back to reference Wier LM, Hatcher MS, Triche EW, Lo AC. Effect of robot-assisted versus conventional body-weight-supported treadmill training on quality of life for people with multiple sclerosis. J Rehabil Res Dev. 2011;48(4):483–92.PubMedCrossRef Wier LM, Hatcher MS, Triche EW, Lo AC. Effect of robot-assisted versus conventional body-weight-supported treadmill training on quality of life for people with multiple sclerosis. J Rehabil Res Dev. 2011;48(4):483–92.PubMedCrossRef
93.
go back to reference Decato TW, Bradley SM, Wilson EL, Hegewald MJ. Repeatability and meaningful change of CPET parameters in healthy subjects. Med Sci Sports Exerc. 2018;50(3):589–95.PubMedCrossRef Decato TW, Bradley SM, Wilson EL, Hegewald MJ. Repeatability and meaningful change of CPET parameters in healthy subjects. Med Sci Sports Exerc. 2018;50(3):589–95.PubMedCrossRef
94.
go back to reference Jaiswal A, Le Jemtel TH. New reference equation for maximal functional capacity. Eur J Prev Cardiol. 2018;25(7):740–1.PubMedCrossRef Jaiswal A, Le Jemtel TH. New reference equation for maximal functional capacity. Eur J Prev Cardiol. 2018;25(7):740–1.PubMedCrossRef
95.
go back to reference Mezzani A, Agostoni P, Cohen-Solal A, Corra U, Jegier A, Kouidi E, et al. Standards for the use of cardiopulmonary exercise testing for the functional evaluation of cardiac patients: a report from the exercise physiology section of the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2009;16(3):249–67.PubMedCrossRef Mezzani A, Agostoni P, Cohen-Solal A, Corra U, Jegier A, Kouidi E, et al. Standards for the use of cardiopulmonary exercise testing for the functional evaluation of cardiac patients: a report from the exercise physiology section of the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2009;16(3):249–67.PubMedCrossRef
96.
go back to reference Austin MW, Ploughman M, Glynn L, Corbett D. Aerobic exercise effects on neuroprotection and brain repair following stroke: a systematic review and perspective. Neurosci Res. 2014;87:8–15.PubMedCrossRef Austin MW, Ploughman M, Glynn L, Corbett D. Aerobic exercise effects on neuroprotection and brain repair following stroke: a systematic review and perspective. Neurosci Res. 2014;87:8–15.PubMedCrossRef
97.
go back to reference Das UN. Molecular basis of health and disease. Dordrecht: Springer Netherlands; 2011.CrossRef Das UN. Molecular basis of health and disease. Dordrecht: Springer Netherlands; 2011.CrossRef
98.
go back to reference Ploughman M, Kelly LP. Four birds with one stone? Reparative, neuroplastic, cardiorespiratory, and metabolic benefits of aerobic exercise poststroke. Curr Opin Neurol. 2016;29(6):684–92.PubMedCrossRef Ploughman M, Kelly LP. Four birds with one stone? Reparative, neuroplastic, cardiorespiratory, and metabolic benefits of aerobic exercise poststroke. Curr Opin Neurol. 2016;29(6):684–92.PubMedCrossRef
99.
go back to reference Li AJ, Katafuchi T, Oda S, Hori T, Oomura Y. Interleukin-6 inhibits long-term potentiation in rat hippocampal slices. Brain Res. 1997;748(1–2):30–8.PubMedCrossRef Li AJ, Katafuchi T, Oda S, Hori T, Oomura Y. Interleukin-6 inhibits long-term potentiation in rat hippocampal slices. Brain Res. 1997;748(1–2):30–8.PubMedCrossRef
100.
go back to reference Rosenthal R. The effect of the experimenter on the results of psychological research. Bull Marit Psychol Assoc. 1964. Rosenthal R. The effect of the experimenter on the results of psychological research. Bull Marit Psychol Assoc. 1964.
101.
go back to reference de Almeida CR, Carneiro K, Fiorelli R, Orsini M, Alvarenga RMP. Urinary dysfunction in women with multiple sclerosis: Analysis of 61 patients from rio de janeiro, Brazil. Neurol Int. 2013;5(4):e23-e.CrossRef de Almeida CR, Carneiro K, Fiorelli R, Orsini M, Alvarenga RMP. Urinary dysfunction in women with multiple sclerosis: Analysis of 61 patients from rio de janeiro, Brazil. Neurol Int. 2013;5(4):e23-e.CrossRef
102.
go back to reference Khan F, Amatya B, Turner-Stokes L. Symptomatic therapy and rehabilitation in primary progressive multiple sclerosis. 2011;2011:740505–Neurol Res Int. Khan F, Amatya B, Turner-Stokes L. Symptomatic therapy and rehabilitation in primary progressive multiple sclerosis. 2011;2011:740505–Neurol Res Int.
Metadata
Title
Vigorous cool room treadmill training to improve walking ability in people with multiple sclerosis who use ambulatory assistive devices: a feasibility study
Authors
Augustine J. Devasahayam
Arthur R. Chaves
Wendy O. Lasisi
Marie E. Curtis
Katie P. Wadden
Liam P. Kelly
Ryan Pretty
Alice Chen
Elizabeth M. Wallack
Caitlin J. Newell
John B. Williams
Hannah Kenny
Matthew B. Downer
Jason McCarthy
Craig S. Moore
Michelle Ploughman
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2020
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-020-1611-0

Other articles of this Issue 1/2020

BMC Neurology 1/2020 Go to the issue